Loss of nuclear receptor RXRα in epidermal keratinocytes promotes the formation of Cdk4-activated invasive melanomas

Pigment Cell and Melanoma Research

Volumn 23, Issue 5, 2010, Pages 635-648

  Hyter, Stephen ^a,b   Bajaj, Gaurav ^a   Liang, Xiaobo ^a   Barbacid, Mariano ^c   Ganguli Indra, Gitali ^a   Indra, Arup Kumar ^a,b,d  

^a Sonia College of Pharmacy   (India)

^b OREGON STATE UNIVERSITY   (United States)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cdk4; ChIP; DMBA; LCM; melanomagenesis; paracrine; RXR ; TPA

Indexed keywords

ALPHA INTERMEDIN; CYCLIN DEPENDENT KINASE 4; FAS ANTIGEN; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; GROWTH FACTOR ALPHA MSH; GROWTH FACTOR ET 1; GROWTH FACTOR HGF; GROWTH FACTOR SCF; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RETINOID X RECEPTOR ALPHA; UNCLASSIFIED DRUG; UVOMORULIN;

AGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL INVASION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; EPIDERMIS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LYMPH NODE; MELANOCYTE; MELANOMA; MELANOMAGENESIS; METASTASIS; MICRODISSECTION; MOUSE; NEVUS; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; CYCLIN-DEPENDENT KINASE 4; DISEASE PROGRESSION; ENDOTHELIN-1; EPIDERMIS; GENE EXPRESSION REGULATION; HEPATOCYTE GROWTH FACTOR; HUMANS; KERATINOCYTES; MELANOMA; MICE; MICE, TRANSGENIC; PARACRINE COMMUNICATION; PROMOTER REGIONS, GENETIC; RETINOID X RECEPTOR ALPHA; SKIN NEOPLASMS;

MUS;

EID: 77956323599     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2010.00732.x     Document Type: Article

References (72)

1. Abdel-Malek, Z., Swope, V.B., Suzuki, I., Akcali, C., Harriger, M.D., Boyce, S.T., Urabe, K. Hearing, V.J. (1995). Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc. Natl Acad. Sci. USA, 92, 1789 1793.
2. Q61K on an INK4a-deficient background. Cancer Res., 65, 4005 4011.
3. Altucci, L. Gronemeyer, H. (2001). Nuclear receptors in cell life and death. Trends Endocrinol. Metab., 12, 460 468.
4. Bedikian, A.Y., Millward, M., Pehamberger, H. et al. (2006). CL-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group. J. Clin. Oncol., 24, 4738 4745.
5. van Biesen, T., Hawes, B.E., Luttrell, D.K., Krueger, K.M., Touhara, K., Porfiri, E., Sakaue, M., Luttrell, L.M. Lefkowitz, R.J. (1995). Receptor-tyrosine-kinase- and G beta gamma-mediated MAP kinase activation by a common signalling pathway. Nature, 376, 781 784.
6. Bullani, R.R., Wehrli, P., Viard-Leveugle, I., Rimoldi, D., Cerottini, J.C., Saurat, J.H., Tschopp, J. French, L.E. (2002). Frequent downregulation of Ras (CD95) expression and function in melanoma. Melanoma Res., 12, 263 270.
7. Chakravarti, N., Lotan, R., Diwan, A.H., Warneke, C.L., Johnson, M.M. Prieto, V.G. (2007). Decreased expression of retinoid receptors in melanoma: entailment in tumorigenesis and prognosis. Clin. Cancer Res., 13, 4817 4824.
8. Chambon, P. (1996). A decade of molecular biology of retinoic acid receptors. FASEB J., 10, 940 954.
9. Chin, L., Garraway, L.A. Fisher, D.E. (2006). Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev., 20, 2149 2182.
10. Cook, P.W., Pittelkow, M.R. Shipley, G.D. (1991). Growth factor-independent proliferation of normal human neonatal keratinocytes: production of autocrine- and paracrine-acting mitogenic factors. J. Cell. Physiol., 146, 277 289.
11. Cui, R., Widlund, H.R., Feige, E. et al. (2007). Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell, 128, 853 864.
12. Curtin, J.A., Fridlyand, J., Kageshita, T. et al. (2005). Distinct sets of genetic alterations in melanoma. N. Engl. J. Med., 353, 2135 2147.
13. Demunter, A., Ahmadian, M.R., Libbrecht, L., Stas, M., Baens, M., Scheffzek, K., Degreef, H., De Wolf-Peeters, C. van den Oord, J.J. (2001). Novel N-ras mutation in malignant melanoma is associated with excellent prognosis. Cancer Res., 61, 4916 4922.
14. Dhomen, N., Reis-Filho, J.S., da Rocha Dias, S., Hayward, R., Savage, K., Delmas, V., Larue, L., Pritchard, C. Marais, R. (2009). Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell, 15, 294 303.
15. Digiovanni, J. (1992). Multistage carcinogenesis in mouse skin. Pharmacol. Ther., 54, 63 128.
16. Fadloun, A., Kobi, D., Pointud, J.C. et al. (2007). The TFIID subunit TAF4 regulates keratinocyte proliferation and has cell-autonomous and non-cell-autonomous tumour suppressor activity in mouse epidermis. Development, 134, 2947 2958.
17. Fisher, G.J. Voorhees, J.J. (1996). Molecular mechanisms of retinoid actions in skin. FASEB J., 10, 1002 1013.
18. Garnett, M.J. Marais, R. (2004). Guilty as charged: B-Raf is a human oncogene. Cancer Cell, 6, 313 319.
19. Garraway, L.A., Widlund, H.R., Rubin, M.A. et al. (2005). Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature, 436, 117 122.
20. Grossman, D., Mcniff, J.M., Li, F. Altieri, D.C. (1999). Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J. Invest. Dermatol., 113, 1076 1081.
21. Haass, N.K. Herlyn, M. (2005). Normal human melanocyte homeostasis as a paradigm for understanding melanoma. J. Invest. Dermatol. Symp. Proc., 10, 153 163.
22. R24C/R24C/ TPras mice. Cancer Res., 66, 2946 2952.
23. Halaban, R., Langdon, R., Birchall, N., Cuono, C., Baird, A., Scott, G., Moellmann, G. McGuire, J. (1988). Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J. Cell Biol., 107, 1611 1619.
24. Halaban, R., Rubin, J.S., Funasaka, Y. et al. (1992). Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene, 7, 2195 2206.
25. Hearing, V.J. Leong, S.P.L. (2006 From melanocytes to melanoma: the progression to malignancy Totowa, NJ: Humana Press).
26. Hirobe, T. (1992). Basic fibroblast growth factor stimulates the sustained proliferation of mouse epidermal melanoblasts in a serum-free medium in the presence of dibutyryl cyclic AMP and keratinocytes. Development, 114, 435 445.
27. Hirobe, T. (2001). Endothelins are involved in regulating the proliferation and differentiation of neonatal mouse epidermal melanocytes in serum-free primary culture. J. Invest. Dermatol. Symp. Proc., 6, 25 31.
28. Hirobe, T. (2005). Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res., 18, 2 12.
29. Hirobe, T., Osawa, M. Nishikawa, S.-I. (2003). Steel factor controls the proliferation and differentiation of neonatal mouse epidermal melanocytes in culture. Pigment Cell Res., 16, 644 655.
30. Hirobe, T., Osawa, M. Nishikawa, S.-I. (2004). Hepatocyte growth factor controls the proliferation of cultured epidermal melanblasts and melanocytes from newborn mice. Pigment Cell Res., 17, 51 61.
31. Hsu, M.Y., Wheelock, M.J., Johnson, K.R. Herlyn, M. (1996). Shifts in cadherin profiles between human normal melanocytes and melanomas. J. Invest. Dermatol. Symp. Proc., 1, 188 194.
32. Ibrahim, N. Haluska, F.G. (2009). Molecular pathogenesis of cutaneous melanocytic neoplasms. Annu. Rev. Pathol., 4, 551 579.
33. Imokawa, G., Yada, Y. Miyagishi, M. (1992). Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J. Biol. Chem., 267, 24675 24680.
34. Indra, A.K., Castaneda, E., Antal, M.C. et al. (2007). Malignant transformation of DMBA/TPA-induced papillomas and nevi in the skin of mice selectively lacking retinoid-X-receptor alpha in epidermal keratinocytes. J. Invest. Dermatol., 127, 1250 1260.
35. Ivanov, V.N., Bhoumik, A. Ronai, Z. (2003). Death receptors and melanoma resistance to apoptosis. Oncogene, 22, 3152 3161.
36. Jamal, S. Schneider, R.J. (2002). UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells. J. Clin. Invest., 110, 443 452.
37. Jimenez, M., Kameyama, K., Maloy, W.L., Tomita, Y. Hearing, V.J. (1988). Mammalian tyrosinase: biosynthesis, processing, and modulation by melanocyte-stimulating hormone. Proc. Natl Acad. Sci. U S A, 85, 3830 3834.
38. Kamb, A., Gruis, N.A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S.V., Stockert, E., Day R.S. III., Johnson, B.E. Skolnick, M.H. (1994). A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436 440.
39. Kastner, P., Gronodona, J.M., Mark, M., Gansmuller, A., LeMeur, M., Decimo, D., Vonesch, J.L., Dolle, P. Chambon, P. (1994). Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell, 78, 987 1003.
40. Kunisada, T., Yoshida, H., Yamazaki, H., Miyamoto, A., Hemmi, H., Nishimura, E., Shultz, L.D., Nishikawa, S. Hayashi, S. (1998). Transgene expression of steel factor in the basal layer of epidermis promotes survival, proliferation, differentiation and migration of melanocyte precursors. Development, 125, 2915 2923.
41. Larue, L. Beermann, F. (2007). Cutaneous melanoma in genetically modified animals. Pigment Cell Res., 20, 485 497.
42. Levy, C., Khaled, M. Fisher, D.E. (2006). MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol. Med., 12, 406 414.
43. Li, M., Chiba, H., Warot, X., Messaddeq, N., Gerard, C., Chambon, P. Metzger, D. (2001). RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations. Development, 128, 675 688.
44. Li, M., Hener, P., Zhang, Z., Kato, S., Metzger, D. Chambon, P. (2006). Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc. Natl Acad. Sci. U S A, 103, 11736 11741.
45. Luger, T.A. Schwarz, T. (1990). Evidence for an epidermal cytokine network. J. Invest. Dermatol., 95, 100S 104S.
46. Mangahas, C.R., dela Cruz, G.V., Scheider, R.J. Jamal, S. (2004). Endothelin-1 upregulates MCAM in melanocytes. J. Invest. Dermatol., 123, 1135 1139.
47. Mangelsdorf, D.J., Borgmeyer, U., Heyman, R.A., Zhou, J.Y., Ong, E.S., Oro, A.E., Kakizuka, A. Evans, R.M. (1992). Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev., 6, 329 344.
48. Mangelsdorf, D.J., Thummel, C., Beato, M. et al. (1995). The nuclear receptor superfamily: the second decade. Cell, 83, 835 839.
49. Metzger, D., Indra, A.K., Li, M., Chapellier, B., Calleja, C., Ghyselinck, N.B. Chambon, P. (2003). Targeted conditional somatic mutagenesis in the mouse: temporally-controlled knock out of retinoid receptors in epidermal keratinocytes. Methods Enzymol., 364, 379 408.
50. Niedojadlo, K., Labedzka, K., Lada, E., Milewska, A. Chwirot, B.W. (2006). Apaf-1 expression in human cutaneous melanoma progression and in pigmented nevi. Pigment Cell Res., 19, 43 50.
51. Otsuka, T., Takayama, H., Sharp, R., Celli, G., LaRochelle, W., Bottaro, D., Ellmore, N., Vieira, W., Owens, J., Anver, M. Merlino, G. et al. (1998). c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res., 58, 5157 5167.
52. INK4a, CDK4, and MC1R genes in human congenital melanocytic naevi. J. Med. Genet., 36, 610 614.
53. Rane, S.G., Dubus, P., Mettus, R.V., Galbreath, E.J., Boden, G., Reddy, E.P. Barbacid, M. (1999). Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat. Genet., 22, 44 52.
54. Recio, J.A. Merlino, G. (2002). Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1. Oncogene, 21, 1000 1008.
55. Rofstad, E.K., Rasmussen, H., Galappathi, K., Mathiesen, B., Nilsen, K. Graff, B.A. (2002). Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. Cancer Res., 62, 1847 1853.
56. Ryu, B., Kim, D.S., Deluca, A.M. Alani, R.M. (2007). Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PLoS ONE, 2, e594.
57. Scott, G.A. (2006) Melanosome Trafficking and Transfer. In The Pigmentary System, J.J. Nordlund, ed Oxford, UK : Blackwell Publishing Ltd pp. 171 180.
58. Solit, D.B., Garraway, L.A., Pratilas, C.A., Sawai, A., Getz, G. et al. (2006). BRAF mutation predicts sensitivity to MEK inhibition. Nature, 439, 358 362.
59. Sotillo, R., Garcia, J.F., Ortega, S., Martin, J., Dubus, P., Barbacid, M. Malumbres, M. (2001). Invasive melanoma in Cdk4-targeted mice. Proc. Natl Acad. Sci. U S A, 98, 13312 13317.
60. Stahl, J.M., Cheung, M., Sharma, A., Trivedi, N.R., Shanmugam, S. Robertson, G.P. (2003). Loss of PTEN promotes tumor development in malignant melanoma. Cancer Res., 63, 2881 2890.
61. Sucov, H.M., Dyson, E., Gumeringer, C.L., Price, J., Chien, K.R. Evans, R.M. (1994). RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev., 8, 1007 1018.
62. Swope, V.B., Medrano, E.E., Smalara, D. Abdel-Malek, Z.A. (1995). Long-term proliferation of human melanocytes is supported by the physiologic mitogens α-melanotropin, endothelin-1, and basic fibroblast growth factor. Exp. Cell Res., 217, 453 459.
63. Tada, A., Pereira, E., Beitner-Johnson, D., Kavanagh, R. Abdel-Malek, Z.A. (2002). Mitogen- and ultraviolet-B-induced signaling pathways in normal human melanocytes. J. Invest. Dermatol., 118, 316 322.
64. Tormo, D., Ferrer, A., Gaffal, E. et al. (2006). Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutation. Am. J. Pathol., 169, 665 672.
65. Tripp, C.S., Blomme, E.A., Chinn, K.S., Hardy, M.M., LaCelle, P. Pentland, A.P. (2003). Epidermal COX-2 induction following ultraviolet irradiation: suggested mechanism for the role of COX-2 inhibition in photoprotection. J. Invest. Dermatol., 121, 853 861.
66. Tsao, H., Mihm, M.C Jr. Sheehan, C. (2003). PTEN expression in normal skin, acquired melanocytic nevi and cutaneous melanoma. J. Am. Acad. Dermatol., 49, 865 872.
67. Vance, K.W. Goding, C.R. (2004). The transcription network regulating melanocyte development and melanoma. Pigment Cell Melanoma Res., 17, 318 325.
68. Wang, D., Stockard, C.R., Harkins, L. et al. (2008). Immunohistochemistry in the evaluation of neovascularization in tumor xenografts. Biotech. Histochem., 83, 179 189.
69. Waseem, N.H. Lane, D.P. (1990). Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar forms. J. Cell Sci. 96 (Pt 1 121 129.
70. Wolfel, T., Hauer, M., Schneider, J., Serrano, M., Wolfel, C., Klehmann-Hieb, E., DE Plaen, E., Hankeln, T., Meyer zum Buschenfeld, K.H. Beach, D. (1995). A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science, 269, 1281 1284.
71. Yamazaki, F., Okamoto, H., Matsumura, Y., Tanaka, K., Kunisada, T. Horio, T. (2005). Development of a new mouse model (xeroderma pigmentosum A-deficient, stem cell factor-transgenic) of ultraviolet B-induced melanoma. J. Invest. Dermatol., 125, 521 525.
72. Zuo, L., Weger, J., Yang, Q., Goldstein, A.M., Tucker, M.A., Walker, G.J., Hayward, N. Dracopoli, N.C. (1996). Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat. Genet., 12, 97 99.